Allergan Natrelle Tissue Expanders Recalled for Lymphoma Risk
Allergan is recalling Natrelle 133 tissue expanders due to FDA safety information regarding a higher incidence of anaplastic large cell lymphoma in patients with textured breast implants.
The agency’s classification
FDA (Devices): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The source text explicitly identifies the agency classification as Class I, which mandates a severity score of 5 (Critical) according to the rubric.
Plain-English summary
Allergan PLC is recalling Natrelle 133 Tissue Expanders with Suture Tabs, BIOCELL Full Height Variable Projection with MAGNA-FINDEr Xact & 21G Needle Infusion Set. The recall covers specific styles including 133FV-T, 133MV-T, 133LV-T, 133SV-T, 133FX-T, 133MX-T, and 133SX-T, across all lots. The products are intended for temporary subcutaneous implantation and require periodic, incremental inflation with sterile saline for injection.
The recall was initiated following notification by the U.S. Food and Drug Administration (FDA) regarding recently updated global safety information. This information indicates a higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants. The FDA has classified this recall as Class I.
The affected products were distributed worldwide and nationwide in the United States, including all fifty states, the District of Columbia, the US Virgin Islands, and Puerto Rico. International distribution included Bermuda, Canada, Chile, Japan, Korea, Thailand, Taiwan, and Vietnam. Patients who have these specific tissue expanders implanted should contact their healthcare provider for guidance regarding the safety information and potential removal.
The recalled product
- Product
- Natrelle 133 Tissue Expanders w/Suture Tabs BIOCELL Full Height Variable Projection with MAGNA-FINDEr Xact & 21G Needle Infusion Set STYLE 133FV-T: 133FV-11-T, 133FV-12-T, 133FV-13-T, 133FV-14-T, 133FV-15-T, 133FV-16-T; STYLE 133MV-T: 133MV-11-T, 133MV-12-T…
- Manufacturer
- Allergan PLC
- Affected units
- 4,026,287
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- ALL LOTS
- Product Code/UDI STYLE 133FV-T: 133FV-11-T 10888628004221
- 133FV-12-T 10888628004238
- 133FV-13-T 10888628004245
- 133FV-14-T 10888628004252
- 133FV-15-T 10888628004269
- 133FV-16-T 10888628004276
- STYLE 133MV-T: 133MV-11-T 10888628004405
- 133MV-12-T 10888628004412
- 133MV-13-T 10888628004429
- 133MV-14-T 10888628004436
- 133MV-15-T 10888628004443
- 133MV-16-T 10888628004450
- STYLE 133LV-T: 133LV-11-T 10888628004344
- 133LV-12-T 10888628004351
- 133LV-13-T 10888628004368
- 133LV-14-T 10888628004375
- 133LV-15-T 10888628004382
- 133LV-16-T 10888628004399
- STYLE 133FX-T: 133FX-11-T 10888628004283
Distribution
Part of a larger recall action
This product is one of 15 recalled by Allergan PLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 15 products in this recall →Related recalls
Same manufacturer · Allergan PLC
See all →- ModerateAllergan Recalls Refresh Contacts Comfort Drops Due to Missing Instructions
FDA (Devices) · 2021-02-10
- ModerateAllergan Recalls Refresh Relieva Preservative-Free Eye Drops for Missing Labeling
FDA (Drugs) · 2021-01-27
- LowAllergan Recalls Skin Medica Acne System Kits for Subpotency
FDA (Drugs) · 2020-08-05
- ModerateAllergan Recalls Subpotent Skin Medica Acne Treatment Lotion
FDA (Drugs) · 2020-08-05
- LowAllergan Recalls Breast Implants With Non-Standard 2D Barcodes
FDA (Devices) · 2019-12-25
Same hazard · anaplastic large cell lymphoma
See all →- SevereAllergan Recalls Textured Breast Implants Due to Lymphoma Risk
FDA (Devices) · 2019-09-18
- CriticalAllergan Recalls Textured Breast Implants Due to Lymphoma Risk
FDA (Devices) · 2019-09-18
Similar recalls
- ModerateAllergan Recalls Natrelle Tissue Expanders Due to Expired Shelf Life
FDA (Devices) · 2015-07-29
- ModerateAllergan Recalls Natrelle Tissue Expanders for Expired Shelf Life
FDA (Devices) · 2015-07-29
- LowAllergan Recalls Natrelle Breast Implants Due to Unreadable 2D Barcodes
FDA (Devices) · 2019-12-25
- ModerateAllergan Recalls Expired Natrelle Breast Implant Sizers
FDA (Devices) · 2015-07-15
- LowAllergan Recalls Breast Implant Sizers Due to Unreadable Barcodes
FDA (Devices) · 2019-12-25
- LowAllergan Recalls Breast Implants With Non-Standard 2D Barcodes
FDA (Devices) · 2019-12-25